1. Home
  2. LYV vs NTRA Comparison

LYV vs NTRA Comparison

Compare LYV & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Nation Entertainment Inc.

LYV

Live Nation Entertainment Inc.

HOLD

Current Price

$181.69

Market Cap

42.1B

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$270.36

Market Cap

39.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYV
NTRA
Founded
2005
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.1B
39.1B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
LYV
NTRA
Price
$181.69
$270.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
15
Target Price
$182.38
$259.07
AVG Volume (30 Days)
1.9M
1.0M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.65
EPS
N/A
N/A
Revenue
$25,201,406,000.00
$210,939,000.00
Revenue This Year
$10.24
$18.08
Revenue Next Year
$9.37
$19.65
P/E Ratio
N/A
N/A
Revenue Growth
8.83
N/A
52 Week Low
$125.34
$134.85
52 Week High
$188.00
$288.04

Technical Indicators

Market Signals
Indicator
LYV
NTRA
Relative Strength Index (RSI) 52.85 57.19
Support Level $158.87 $261.63
Resistance Level $188.00 $288.04
Average True Range (ATR) 4.96 10.88
MACD -0.51 -1.77
Stochastic Oscillator 58.43 63.78

Price Performance

Historical Comparison
LYV
NTRA

About LYV Live Nation Entertainment Inc.

Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 51 countries, Live Nation promotes concerts globally and it owned, operated, or had exclusive booking rights to more than 400 venues worldwide at the end of 2025, which the firm says makes it the second-largest operator of music venues globally. In 2025, Live Nation promoted nearly 55,000 events, drawing roughly 160 million fans. Ticketmaster is a dominant global ticketing service, selling nearly 650 million tickets in 2025.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: